Skip to main content
. 2020 Dec 1;13(12):3033–3043.

Figure 5.

Figure 5

NCF2 has strong oncogenic function in ESCC cells. A. Western blotting reveals that NCF2 was efficiently knocked down by the treatment of NCF2-shRNA-1 or NCF2-shRNA-2 in TE1 ESCC cells. B. Wound-healing show that NCF2-ilenced TE1 had lower invasive capacity (down) as compared with that in control TE1 cells. C. Representative images of decreased foci formation in monolayer culture induced by NCF2 silenced in ESCC cells. Data are the means ± sd of three independent experiments. P<0.01 by Student’s t-test. D. Transwell invasion assays show that NCF2-silenced TE1 had lower invasive capacity (down) as compared with that in control TE1 cells. Data are the mean ± sd of three independent experiments. P<0.05, P<0.05 by Student’s t-test. E. Rate of cell growth of TE-sh1, TE1-sh2 and sh-Control ESCC cells by CCK-8 kit. P<0.05, P<0.05 by Student’s t-test.